C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study
By M. Rutter, James B. Meigs, Lisa Sullivan, Ralph B. D’Agostino, Peter W. F. Wilson. Circulation, 2004
690 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/06c61ad01b80de98154a3993234841ea4ca72416
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Epidemiology
- J. Bastard
- James B. Meigs
- Peter W. F. Wilson
- E. Ford
- Ralph B. D’Agostino
- Richard P. Mayeux
- Yaakov Stern
Citations in the corpus
- Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. (2005, background): “For seven studies (13,15,18,19,21,23,24) with eight estimates of relative risk that excluded participants with diabetes or Figure 1—A: Associations between metabolic syndrome, using the NCEP definition, and all-cause mortality.”
- The metabolic syndrome: time for a critical appraisal (2005, neutral): “drome, and incident cardiovascular events [68, 73, 74].”
- Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. (2007, methodology): “Other laboratory measurements included levels of fasting and 2-hour OGTT insulin (determined using a commercially available assay [DPC Coat-a-Count; Diagnostics Products Corporation, Los Angeles, Calif]), total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and C-reactive ”
- The metabolically healthy but obese individual presents a favorable inflammation profile. (2005, result): “This finding is in line with previous studies that suggest that CRP levels could be an important factor associated with variations in insulin sensitivity (7, 9, 24).”